Cost-effectiveness analysis of top-down versus step-up strategies in patients with newly diagnosed active luminal Crohn’s disease

TD is a cost-effective treatment in newly diagnosed CD patients with luminal moderate-to-severe disease, and sensitivity analysis showed the result to be robust. </AbstractSection> Copyright Springer-Verlag 2013

MoreLess

Year of publication:	2013
Authors:	Marchetti, Monia ; Liberato, Nicola ; Sabatino, Antonio ; Corazza, Gino
Published in:	The European Journal of Health Economics. - Springer. - Vol. 14.2013, 6, p. 853-861
Publisher:	Springer
Subject:	Cost-effectiveness \| Crohn’s disease \| Infliximab \| Step-up \| Top-down

More details

Extent:	text/html
Type of publication:	Article
Source:	RePEc - Research Papers in Economics

Persistent link: https://www.econbiz.de/10010993982